Press Release Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna’s Investigational Vaccine Against Bundibugyo Ebolavirus Aug 4
Press Release Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates Jul 31